Neola Medical Q4: Vital clinical data incoming - Redeye - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Aktieanalys

Neola Medical Q4: Vital clinical data incoming - Redeye

{newsItem.title}

Redeye provides an update following Neola Medical’s Q4 2024 report. The report aligned with our expectations, and we look forward to an important 2025, including clinical validation of the Neola device. We make some model adjustments based on the report, rendering an updated fair value range.

Länk till analysen i sin helhet: https://www.redeye.se/research/1075044/neola-medical-q4-vital-clinical-data-incoming?utm_source=finwire&utm_medium=RSS

Nyheter om Neola Medical

Läses av andra just nu

Om aktien Neola Medical

Senaste nytt